Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Theriva Biologics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q1 2026
- Shares held
- 1.98M
- +15.1K (+0.8%) vs. Q1 2026
- Total value
- $495.5K
- +$110.2K (+28.6%) vs. Q1 2026
- New holders
- 6
- 5 more added
- Sold out
- 2
- 6 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $495.5K |
| Q1 2026 | 22 | $385.4K |
| Q4 2025 | 21 | $272.4K |
| Q3 2025 | 20 | $177.0K |
| Q2 2025 | 17 | $126.3K |
| Q1 2025 | 11 | $209.8K |
| Q4 2024 | 10 | $60.3K |
| Q3 2024 | 18 | $678.6K |
| Q2 2024 | 22 | $327.6K |
| Q1 2024 | 24 | $1.37M |
| Q4 2023 | 24 | $452.5K |
| Q3 2023 | 21 | $572.8K |
| Q2 2023 | 18 | $1.01M |
| Q1 2023 | 19 | $724.6K |
| Q4 2022 | 22 | $479.1K |
| Q3 2022 | 26 | $1.15M |
| Q2 2022 | 33 | $2.52M |
| Q1 2022 | 35 | $3.23M |
| Q4 2021 | 35 | $3.24M |
| Q3 2021 | 36 | $3.32M |
| Q2 2021 | 31 | $3.91M |
| Q1 2021 | 32 | $5.80M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Theriva Biologics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 486,179 | $121.5K | 0.00% | +293,775+152.7% | Added |
| Jane Street Group, LLC | 331,922 | $83.0K | 0.00% | +154,888+87.5% | Added |
| Geode Capital Management, LLC | 294,021 | $73.6K | 0.00% | −156,242−34.7% | Reduced |
| Vanguard Fiduciary Trust Co | 241,780 | $60.4K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 112,076 | $28.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 87,138 | $22.0K | 0.00% | −166,080−65.6% | Reduced |
| Northern Trust Corp | 82,700 | $20.7K | 0.00% | +82,700 | New |
| Renaissance Technologies LLC | 63,710 | $15.9K | 0.00% | +63,710 | New |
| UBS Group AG | 61,053 | $15.3K | 0.00% | −164,571−72.9% | Reduced |
| XTX Topco Ltd | 53,868 | $13.5K | 0.00% | −40,752−43.1% | Reduced |
| Ground Swell Capital, LLC | 35,292 | $8.83K | 0.01% | +35,292 | New |
| Boothbay Fund Management, LLC | 27,646 | $6.92K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 24,064 | $6.02K | 0.00% | +24,064 | New |
| Morgan Stanley | 20,299 | $5.08K | 0.00% | −3,303−14.0% | Reduced |
| Two Sigma Securities, LLC | 19,748 | $4.94K | 0.00% | −85,493−81.2% | Reduced |
| Two Sigma Investments, LP | 15,456 | $3.87K | 0.00% | +15+0.1% | Added |
| Schwarz Dygos Wheeler Investment Advisors LLC | 15,000 | $3.75K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,504 | $1.88K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 441 | $110 | 0.00% | +433+5,412.5% | Added |
| SBI Securities Co., Ltd. | 358 | $90 | 0.00% | +227+173.3% | Added |
| Northwestern Mutual Wealth Management Co | 100 | $25 | 0.00% | +100 | New |
| IFP Advisors, Inc | 11 | $3 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 5 | $1 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 3 | $1 | 0.00% | +3 | New |
| Danske Bank A/S | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 0 | $0 | 0.00% | −22,280−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,391−100.0% | Sold out |